Short answer: elite athletes as a group tend to live longer than the general population, with the clearest longevity advantage seen in endurance and mixed sports. But there is no scientifically robust league table saying that tennis players live exactly X years, swimmers Y years, and boxers Z years. The better evidence uses standardized mortality ratios, matched cohorts and cause-specific mortality.
That distinction matters. A sport can be associated with lower overall mortality while still carrying a higher risk of a particular disease. American football is now one of the clearest examples.
What the broad evidence says
A 2014 meta-analysis combined 10 cohort studies containing 42,807 elite athletes. The pooled all-cause standardized mortality ratio was 0.67 compared with the general population. In plain English, the observed mortality rate was about one-third lower than expected, although the studies were highly heterogeneous. Cardiovascular mortality was also lower (SMR 0.73), as was cancer mortality (SMR 0.60).
Source: Elite athletes live longer than the general population: a meta-analysis, Mayo Clinic Proceedings, 2014.
A later systematic review of 54 peer-reviewed studies reached a similar overall conclusion. Most studies reported superior longevity among elite athletes, with especially consistent findings in endurance and mixed sports. Power-sport results were less consistent.
Source: Do Elite Athletes Live Longer? A Systematic Review of Mortality and Longevity in Elite Athletes, 2015.
A useful long-term comparison: endurance, team and power athletes
A Finnish cohort followed 2,363 former elite male athletes and 1,657 controls for roughly 50 years. Median life expectancy was 79.1 years in endurance athletes, 78.8 years in team-sport athletes, and 72.9 years in controls. The mortality advantage was strongest in endurance athletes. Power athletes showed a much smaller and statistically uncertain advantage.
Importantly, this study also shows why “which sport wins?” is too simple. Power athletes as a group did not show the same cardiovascular advantage, and boxers within that group had substantially higher dementia mortality. The risk profile depends on what kind of stress the sport imposes, not merely on whether someone was an athlete.
Source: All-cause and disease-specific mortality among male, former elite athletes: an average 50-year follow-up, British Journal of Sports Medicine, 2015.
Professional football (soccer): generally lower overall mortality
A study published in 2026 examined 7,620 male professional English footballers born between 1900 and 1972. By the end of 2022, 3,571 had died versus 4,242 deaths expected from age-matched population rates. The standardized mortality ratio was 0.84 (95% CI 0.81–0.88), indicating lower overall mortality than the general male population.
Source: Professional male English footballers of the 20th century had lower death rates than the general population, Science and Medicine in Football, 2026.
American football: lower overall mortality, much higher neurodegenerative mortality
The old claim that NFL players have an average lifespan of only 53–59 years is misleading and I am removing it from this article. A much larger 2026 study gives a more interesting answer.
Researchers studied 19,824 NFL players who debuted from 1960 through 2019 and linked them to National Death Index data through 2023. Overall mortality was lower than expected: SMR 0.70. Cancer mortality (0.64) and cardiovascular mortality (0.74) were also lower.
But neurodegenerative mortality went sharply in the opposite direction: SMR 3.94. Dementia mortality was 3.80 times expected, ALS 4.55 times expected, and Parkinson’s disease 3.88 times expected. After modeling competing risks, the excess neurodegenerative mortality remained about threefold.
Source: Neurodegenerative mortality among National Football League Players, EClinicalMedicine, 2026.
A different comparison helps control for the general “healthy athlete” effect. A 2019 study compared 3,419 NFL players with 2,708 MLB players. NFL players had higher all-cause mortality (HR 1.26), cardiovascular mortality (HR 2.40), and neurodegenerative mortality (HR 2.99) than professional baseball players. That does not mean NFL players die younger than the general public; it means their risk looks worse when the comparison group is another elite professional sport.
Source: Mortality Among Professional American-Style Football Players and Professional American Baseball Players, JAMA Network Open, 2019.
So which athletes appear to live longest?
The most defensible answer is a category, not a podium. Elite endurance athletes and athletes in mixed aerobic/anaerobic sports show the most consistent longevity advantage in the published literature. Team-sport athletes also often do well. Power-sport findings are less consistent, and sports involving repeated head impacts can carry important neurological risks even when overall mortality remains low.
The strongest studies are easier to compare when their actual outcome measures are placed side by side:
| Study / population | Comparison | Result | What it means |
|---|---|---|---|
| Meta-analysis, 42,807 elite athletes | General population | All-cause SMR 0.67; cardiovascular 0.73; cancer 0.60 | Elite athletes as a group had substantially lower observed mortality. |
| Finnish 50-year follow-up | Former elite athletes vs controls | Median life expectancy: endurance 79.1 y; team sports 78.8 y; controls 72.9 y | The clearest longevity advantage appeared in endurance and team-sport athletes. |
| 7,620 English professional footballers | Age-matched male population | All-cause SMR 0.84 | Professional footballers had lower overall mortality. |
| 19,824 NFL players | General population | All-cause SMR 0.70; neurodegenerative SMR 3.94 | Lower mortality overall can coexist with a large sport-specific neurological risk. |
This is why a simple sport-by-sport podium can be misleading: different studies report life expectancy, standardized mortality ratios and cause-specific mortality in different populations.
Claims that marathoners average 79 years, tennis players 80, golfers 77–80, boxers 60–65, or wrestlers 55–60 sound precise but usually mix incompatible cohorts, eras and populations. I no longer think those numbers should be presented as if they were directly comparable measurements.
Why elite athletes may outlive the public
Training is probably part of the explanation, especially through cardiovascular fitness, body composition and metabolic health. But observational athlete studies also contain strong selection effects. Elite athletes are unusual before they become elite: genetics, childhood health, socioeconomic factors, smoking rates, medical screening and personality can all differ from the general population.
This is sometimes called the healthy-worker or healthy-athlete effect. It means we should not read an SMR of 0.67 as proof that elite training itself reduces mortality by exactly 33%. The observation is real; the causal fraction attributable to training is harder to identify.
My interpretation: sustainability probably matters more than extremity
I still suspect that an activity you can enjoy and sustain for decades is a better longevity strategy than repeatedly pushing to exhaustion. But that is an interpretation, not something established by the athlete mortality studies above. My separate AI facial-age experiment is also exploratory and cannot establish that a particular training style slows biological aging.
Bottom line
Elite sport is generally associated with longer survival, especially in endurance and mixed sports. The important exception is not necessarily shorter life overall, but sport-specific causes of harm. The newest NFL evidence illustrates this perfectly: fewer deaths overall, yet roughly four times the expected neurodegenerative mortality. Longevity is not one number.
Key references
Garatachea et al., 2014 — meta-analysis of 42,807 elite athletes
Lemez & Baker, 2015 — systematic review of elite-athlete longevity
Kettunen et al., 2015 — 50-year follow-up of Finnish elite athletes
Sellers et al., 2026 — English professional footballers
Luster et al., 2026 — NFL neurodegenerative mortality
Nguyen et al., 2019 — NFL versus MLB mortality
Medical information
This article may contain published medical evidence, clinical context, personal observations, or hypotheses. These are not equivalent levels of evidence. See the Editorial & Medical Review Policy and Medical Disclaimer. This content is educational and does not provide an individual diagnosis or treatment plan.